Funding announcement
Melbourne company’s antiviral spray could offer protection against COVID-19
Firebrick Pharma's nasal spray, in late-stage trials, may guard against coronavirus; its founder says it could be regulated as a disinfectant, and the company raised Series C funding in 2019.